3652 results for «303»
3652 results
Challenging Cases
15 Dec 2021 – From GulfPCR-GIM 2021
This session comprises a series of cases presenting complications to be discussed: if you were faced with them, what would be your strategy? Watch it and compare your methods with the ones of your peers!
GulfPCR-GIM 2021 Opening Ceremony
15 Dec 2021 – From GulfPCR-GIM 2021
Listen to the enthusiastic speeches of the 4 Course Directors who are happy to open this 10th edition of the GulfPCR-GIM Congress and to present the main highlights of a program that promises to be dense and rich.
Ultra low contrast PCI in chronic kidney disease: what tools do we have? How to perform? How to achieve optimal outcome? How low can you go?
22 Dec 2021 – From GulfPCR-GIM 2021
Don't miss this session to understand how to perform ultra-low contrast PCI in complex disease and to discover SyncVision co-registration, Dynamic Coronary Roadmap, and the benefits for Azurion to perform ultra-low contrast PCI.
Mastering PCI in patients with complex lesions, ACS and HBR
22 Dec 2021 – From GulfPCR-GIM 2021
Watch this video if you wish to learn how to treat patients with complex anatomy, HBR feature, and presenting with ACS, to discuss the latest evidence about DAPT in HBR patients with acute coronary syndrome, and to ask open questions about DAPT for HBR patients.
Align to a line: improve clinical outcome of current and future patients with the Evolut platform
22 Dec 2021 – From GulfPCR-GIM 2021
Thanks to this session, aimed at revealing the exceptional performance of Evolut PRO+, learn key considerations for patients with longer life expectancy and explore the pathway to a single-digit pacemaker post-TAVI.
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
Optimising TAVI results in patients with small aortic annuli
22 Dec 2021 – From GulfPCR-GIM 2021
This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.
Complete revascularisation: from defining PCI strategy to PCI optimisation
22 Dec 2021 – From GulfPCR-GIM 2021
In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.
Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial
20 Sep 2022
Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.
It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR
29 Mar 2025
Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.
Author
Author
